True to its name, this firm provides home healthcare to NHS, privately insured and self-funded patients. About 600 clinicians care for 150,000 patients a year with home treatments ranging from chemotherapy to blood transfusions and orthopaedic rehabilitation. Majority owned by the private equity firm Vitruvian, the Burton upon Trent company is run by chief executive Mike Gordon, 56. It has benefited from continued pressure on the NHS to reduce costs, and 2012 sales broke the £1bn level for the first time, reaching £1.1bn.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.